{
 "cells": [
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# First implementation of a GNN (GCN)\n",
    "In this notebook, we build the graph from an initial dataframe, and we execute the first implementation of our GNN, which contains 1 convolutive layer and 1 fully-connected layer.\n",
    "\n",
    "## Notebook plan : \n",
    "1. Building the graph\n",
    "2. Building the GCN"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "from models.BuildGraph import BuildGraph\n",
    "from models.GCN import GCN"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 1. Building the graph\n",
    "Here, we split the patients by tumour type. We merge tumour types if they contain only 1 patient."
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Reading the dataset"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Anonymous ID</th>\n",
       "      <th>EGA ID</th>\n",
       "      <th>Tumour type</th>\n",
       "      <th>Sex</th>\n",
       "      <th>Line of therapy</th>\n",
       "      <th>Immunotherapy regimen</th>\n",
       "      <th>Cohort</th>\n",
       "      <th>Reason for discontinuation</th>\n",
       "      <th>Best response</th>\n",
       "      <th>Age at advanced disease diagnosis</th>\n",
       "      <th>...</th>\n",
       "      <th>Alive_0</th>\n",
       "      <th>Time to progression (days)</th>\n",
       "      <th>Progression_1</th>\n",
       "      <th>Clinical benefit</th>\n",
       "      <th>CD8+ T cell score</th>\n",
       "      <th>Exome mut per mb</th>\n",
       "      <th>Genome mut per mb</th>\n",
       "      <th>CD274 expression</th>\n",
       "      <th>M1M2 expression</th>\n",
       "      <th>Lymph related</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>14891</td>\n",
       "      <td>EGAD00001001961</td>\n",
       "      <td>LUNG</td>\n",
       "      <td>F</td>\n",
       "      <td>8</td>\n",
       "      <td>Nivolumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Mixed</td>\n",
       "      <td>45</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>179</td>\n",
       "      <td>1</td>\n",
       "      <td>NCB</td>\n",
       "      <td>0.351869</td>\n",
       "      <td>11.095310</td>\n",
       "      <td>23.0729</td>\n",
       "      <td>4.1689</td>\n",
       "      <td>55.51575</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>18624</td>\n",
       "      <td>EGAD00001002047</td>\n",
       "      <td>AECA</td>\n",
       "      <td>F</td>\n",
       "      <td>10</td>\n",
       "      <td>Nivolumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Stable disease</td>\n",
       "      <td>47</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>148</td>\n",
       "      <td>1</td>\n",
       "      <td>NCB</td>\n",
       "      <td>0.071464</td>\n",
       "      <td>3.876336</td>\n",
       "      <td>5.4552</td>\n",
       "      <td>0.7910</td>\n",
       "      <td>9.32352</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>21392</td>\n",
       "      <td>EGAD00001002544</td>\n",
       "      <td>OV</td>\n",
       "      <td>F</td>\n",
       "      <td>6</td>\n",
       "      <td>Monalizumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Physician assessed SD</td>\n",
       "      <td>57</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>79</td>\n",
       "      <td>1</td>\n",
       "      <td>NCB</td>\n",
       "      <td>0.040394</td>\n",
       "      <td>2.415688</td>\n",
       "      <td>4.1274</td>\n",
       "      <td>4.0377</td>\n",
       "      <td>50.12008</td>\n",
       "      <td>Lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>21516</td>\n",
       "      <td>EGAD00001002546</td>\n",
       "      <td>SKCM</td>\n",
       "      <td>F</td>\n",
       "      <td>3</td>\n",
       "      <td>Ipilimumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Death</td>\n",
       "      <td>Not evaluable</td>\n",
       "      <td>29</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>11</td>\n",
       "      <td>0</td>\n",
       "      <td>NCB</td>\n",
       "      <td>0.052774</td>\n",
       "      <td>6.235845</td>\n",
       "      <td>11.4871</td>\n",
       "      <td>0.6006</td>\n",
       "      <td>1.58550</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>22186</td>\n",
       "      <td>EGAD00001001966</td>\n",
       "      <td>LUNG</td>\n",
       "      <td>F</td>\n",
       "      <td>4</td>\n",
       "      <td>Atezolizumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Stable disease</td>\n",
       "      <td>52</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>80</td>\n",
       "      <td>1</td>\n",
       "      <td>NCB</td>\n",
       "      <td>0.009323</td>\n",
       "      <td>4.606660</td>\n",
       "      <td>7.1503</td>\n",
       "      <td>1.8234</td>\n",
       "      <td>38.42695</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>92</th>\n",
       "      <td>39280</td>\n",
       "      <td>EGAD00001004933</td>\n",
       "      <td>LUNG</td>\n",
       "      <td>M</td>\n",
       "      <td>2</td>\n",
       "      <td>Pembrolizumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Toxicity</td>\n",
       "      <td>Physician Assessed SD</td>\n",
       "      <td>60</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>401</td>\n",
       "      <td>0</td>\n",
       "      <td>DCB</td>\n",
       "      <td>0.695396</td>\n",
       "      <td>84.998501</td>\n",
       "      <td>96.4079</td>\n",
       "      <td>8.4768</td>\n",
       "      <td>86.62561</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>94</th>\n",
       "      <td>37899</td>\n",
       "      <td>EGAD00001005838</td>\n",
       "      <td>CHOL</td>\n",
       "      <td>F</td>\n",
       "      <td>2</td>\n",
       "      <td>Nivolumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Death</td>\n",
       "      <td>Physician assessed PR</td>\n",
       "      <td>38</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>96</td>\n",
       "      <td>0</td>\n",
       "      <td>NCB</td>\n",
       "      <td>0.818233</td>\n",
       "      <td>2.247151</td>\n",
       "      <td>2.7416</td>\n",
       "      <td>11.2704</td>\n",
       "      <td>47.97376</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>95</th>\n",
       "      <td>37775</td>\n",
       "      <td>EGAD00001004934</td>\n",
       "      <td>HNSC</td>\n",
       "      <td>M</td>\n",
       "      <td>1</td>\n",
       "      <td>Avelumab/OX40 agonist PF-04518600</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Stable disease</td>\n",
       "      <td>69</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>69</td>\n",
       "      <td>1</td>\n",
       "      <td>NCB</td>\n",
       "      <td>0.018982</td>\n",
       "      <td>3.848247</td>\n",
       "      <td>5.8036</td>\n",
       "      <td>8.7136</td>\n",
       "      <td>5.13403</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>96</th>\n",
       "      <td>38313</td>\n",
       "      <td>EGAD00001005844</td>\n",
       "      <td>ACC</td>\n",
       "      <td>F</td>\n",
       "      <td>3</td>\n",
       "      <td>Avelumab/Debio1143 (SMAC mimetic)</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Toxicity</td>\n",
       "      <td>Partial response</td>\n",
       "      <td>34</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>51</td>\n",
       "      <td>1</td>\n",
       "      <td>NCB</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>5.617878</td>\n",
       "      <td>7.7940</td>\n",
       "      <td>0.0688</td>\n",
       "      <td>0.51364</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>97</th>\n",
       "      <td>38207</td>\n",
       "      <td>EGAD00001005850</td>\n",
       "      <td>LUNG</td>\n",
       "      <td>F</td>\n",
       "      <td>1</td>\n",
       "      <td>Pembrolizumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Physician assessed SD</td>\n",
       "      <td>50</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>104</td>\n",
       "      <td>1</td>\n",
       "      <td>NCB</td>\n",
       "      <td>0.110416</td>\n",
       "      <td>33.763449</td>\n",
       "      <td>53.2769</td>\n",
       "      <td>23.8818</td>\n",
       "      <td>11.22022</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>82 rows × 21 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    Anonymous ID           EGA ID Tumour type Sex Line of therapy   \n",
       "0          14891  EGAD00001001961        LUNG   F               8  \\\n",
       "1          18624  EGAD00001002047        AECA   F              10   \n",
       "2          21392  EGAD00001002544          OV   F               6   \n",
       "3          21516  EGAD00001002546        SKCM   F               3   \n",
       "4          22186  EGAD00001001966        LUNG   F               4   \n",
       "..           ...              ...         ...  ..             ...   \n",
       "92         39280  EGAD00001004933        LUNG   M               2   \n",
       "94         37899  EGAD00001005838        CHOL   F               2   \n",
       "95         37775  EGAD00001004934        HNSC   M               1   \n",
       "96         38313  EGAD00001005844         ACC   F               3   \n",
       "97         38207  EGAD00001005850        LUNG   F               1   \n",
       "\n",
       "                Immunotherapy regimen Cohort Reason for discontinuation   \n",
       "0                           Nivolumab  Naive                Progression  \\\n",
       "1                           Nivolumab  Naive                Progression   \n",
       "2                         Monalizumab  Naive                Progression   \n",
       "3                          Ipilimumab  Naive                      Death   \n",
       "4                        Atezolizumab  Naive                Progression   \n",
       "..                                ...    ...                        ...   \n",
       "92                      Pembrolizumab  Naive                   Toxicity   \n",
       "94                          Nivolumab  Naive                      Death   \n",
       "95  Avelumab/OX40 agonist PF-04518600  Naive                Progression   \n",
       "96  Avelumab/Debio1143 (SMAC mimetic)  Naive                   Toxicity   \n",
       "97                      Pembrolizumab  Naive                Progression   \n",
       "\n",
       "            Best response  Age at advanced disease diagnosis  ...  Alive_0   \n",
       "0                   Mixed                                 45  ...        1  \\\n",
       "1          Stable disease                                 47  ...        1   \n",
       "2   Physician assessed SD                                 57  ...        1   \n",
       "3           Not evaluable                                 29  ...        1   \n",
       "4          Stable disease                                 52  ...        1   \n",
       "..                    ...                                ...  ...      ...   \n",
       "92  Physician Assessed SD                                 60  ...        1   \n",
       "94  Physician assessed PR                                 38  ...        1   \n",
       "95         Stable disease                                 69  ...        1   \n",
       "96       Partial response                                 34  ...        1   \n",
       "97  Physician assessed SD                                 50  ...        0   \n",
       "\n",
       "    Time to progression (days)  Progression_1  Clinical benefit   \n",
       "0                          179              1               NCB  \\\n",
       "1                          148              1               NCB   \n",
       "2                           79              1               NCB   \n",
       "3                           11              0               NCB   \n",
       "4                           80              1               NCB   \n",
       "..                         ...            ...               ...   \n",
       "92                         401              0               DCB   \n",
       "94                          96              0               NCB   \n",
       "95                          69              1               NCB   \n",
       "96                          51              1               NCB   \n",
       "97                         104              1               NCB   \n",
       "\n",
       "   CD8+ T cell score  Exome mut per mb  Genome mut per mb  CD274 expression   \n",
       "0           0.351869         11.095310            23.0729            4.1689  \\\n",
       "1           0.071464          3.876336             5.4552            0.7910   \n",
       "2           0.040394          2.415688             4.1274            4.0377   \n",
       "3           0.052774          6.235845            11.4871            0.6006   \n",
       "4           0.009323          4.606660             7.1503            1.8234   \n",
       "..               ...               ...                ...               ...   \n",
       "92          0.695396         84.998501            96.4079            8.4768   \n",
       "94          0.818233          2.247151             2.7416           11.2704   \n",
       "95          0.018982          3.848247             5.8036            8.7136   \n",
       "96          0.000000          5.617878             7.7940            0.0688   \n",
       "97          0.110416         33.763449            53.2769           23.8818   \n",
       "\n",
       "    M1M2 expression      Lymph related  \n",
       "0          55.51575  Non-lymph related  \n",
       "1           9.32352  Non-lymph related  \n",
       "2          50.12008      Lymph related  \n",
       "3           1.58550  Non-lymph related  \n",
       "4          38.42695  Non-lymph related  \n",
       "..              ...                ...  \n",
       "92         86.62561  Non-lymph related  \n",
       "94         47.97376  Non-lymph related  \n",
       "95          5.13403  Non-lymph related  \n",
       "96          0.51364  Non-lymph related  \n",
       "97         11.22022  Non-lymph related  \n",
       "\n",
       "[82 rows x 21 columns]"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df = pd.read_excel('data/Supplemental-table1.xlsx')\n",
    "df = df.loc[df[\"Cohort\"] == \"Naive\"]\n",
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "buildgraph = BuildGraph(df)"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Compute the adjacency matrix"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([[0., 0., 0., ..., 0., 0., 1.],\n",
       "       [0., 0., 0., ..., 0., 0., 0.],\n",
       "       [0., 0., 0., ..., 0., 0., 0.],\n",
       "       ...,\n",
       "       [0., 0., 0., ..., 0., 0., 0.],\n",
       "       [0., 0., 0., ..., 0., 0., 0.],\n",
       "       [1., 0., 0., ..., 0., 0., 0.]])"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "buildgraph.compute_adjacency_matrix(\"Tumour type\")\n",
    "display(buildgraph.A)"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Build the graph"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "features_label = [\"CD8+ T cell score\",\"Exome mut per mb\"]\n",
    "y_label = [\"Clinical benefit\"]\n",
    "\n",
    "buildgraph.create_graph(features_label, y_label)"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Show the graph"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x700 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "buildgraph.show_graph(\"Graph with split per tumour type\",\"tumour-type.png\")"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 2. Building the GCN"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Formatting data\n",
    "We convert the Networkx graph to a PyTorch Geometric graph."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Data(x=[82, 2], edge_index=[2, 860], y=[82])"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from torch_geometric.utils.convert import from_networkx\n",
    "\n",
    "pyg_graph = from_networkx(buildgraph.G)\n",
    "pyg_graph"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Instanciate the GCN and test a forward pass"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "GCN(\n",
      "  (conv): GCNConv(2, 2)\n",
      "  (linear): Linear(in_features=2, out_features=1, bias=True)\n",
      ")\n"
     ]
    }
   ],
   "source": [
    "model = GCN(2)\n",
    "print(model)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Proba de réponse du patient 0 : 0.6382941007614136\n"
     ]
    }
   ],
   "source": [
    "out, h = model(pyg_graph.x, pyg_graph.edge_index)\n",
    "print(f\"Proba de réponse du patient 0 : {out[0].item()}\")"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.6"
  },
  "orig_nbformat": 4
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
